CD47 and neoplasm: Recently, disruption of the disialoganglioside GD2/Siglec-7 axis with a GD2 antibody in combination with a CD47 antibody resulted in tumor eradication in syngeneic and xenograft mouse models of neuroblastoma by recruitment of macrophages (22).